Table 1 Association between lncRNA AFAP1-AS1 expression and clinicopathological characteristics in NSCLC patients
From: Overexpression of lncRNA AFAP1-AS1 as a diagnostic biomarker in non-small cell lung cancer
Clinical parameter | No. of cases (%) | Mean expression (2−ΔΔCt) | P-value |
|---|---|---|---|
Smoking | 0.427 | ||
Yes | 39 (43) | 14.12 | |
No | 51 (57) | 13.35 | |
Age (Year) | 0.643 | ||
≤ 55 | 50 (62) | 12.16 | |
> 55 | 40 (38) | 15.59 | |
Side of involvement | 0.993 | ||
Right | 58 (64) | 13.28 | |
Left | 32 (36) | 14.41 | |
Gender | 0.797 | ||
Male | 65 (72) | 14.62 | |
Female | 25 (28) | 11.26 | |
Tumor size (cm) | 0.015 | ||
≥ 5 | 64 (72) | 15.43 | |
< 5 | 26 (28) | 9.40 | |
Lymph metastasis | 0.686 | ||
No | 42 (47) | 13.57 | |
Yes | 48 (53) | 13.78 | |
Differentiation | 0.728 | ||
Poor | 42 (47) | 12.29 | |
Moderate/high | 48 (53) | 14.90 | |
Stage | |||
I/II | 45 (50) | 9.98 | 0.019 |
III/IV | 45 (50) | 17.39 |